1A2
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Coadministration of fluvoxamine increases serum concentrations of haloperidol.
Journal:
J Clin Psychopharmacol
Authors:
Daniel DG, Randolph C, Jaskiw G, Handel S, Williams T, Abi-Dargham A, Shoaf S, Egan M, Elkashef A, Liboff S, Linnoila M.
Publication Date:
1994
PubMed Id: 7806690
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
|
2B6
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Pharmacokinetics of efavirenz when co-administered with rifampin in TB/HIV co-infected patients: pharmacogenetic effect of CYP2B6 variation.
Journal:
J Clin Pharmacol.
Authors:
Kwara A, Lartey M, Sagoe KW, Xexemeku F, Kenu E, Oliver-Commey J, Boima V, Sagoe A, Boamah I, Greenblatt DJ, Court MH.
Publication Date:
2008
PubMed Id: 18728241
Rifampin enhances cytochrome P450 (CYP) 2B6-mediated efavirenz 8-hydroxylation in healthy volunteers
Journal:
Drug Metab Pharmacokinet . 2016 Apr;31(2):107-16. doi: 10.1016/j.dmpk.2015.07.002. Epub 2015 Jul 29.
Authors:
Cho DY, Shen JH, Lemler SM, Skaar TC, Li L, Blievernicht J, Zanger UM, Kim KB, Shin JG, Flockhart DA, Desta Z.
PubMed Id: 27053325
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
|
2C8
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
|
2C9
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Genetic susceptibility to nonsteroidal anti-inflammatory drug-related gastroduodenal bleeding: role of cytochrome P450 2C9 polymorphisms.
Journal:
Gastroenterology
Authors:
Pilotto A, Seripa D, Franceschi M, Scarcelli C, Colaizzo D, Grandone E, Niro V, Andriulli A, Leandro G, Di Mario F, Dallapiccola B.
Publication Date:
2007
PubMed Id: 17681167
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
CYP2C9 Ile359Leu polymorphism, plasma irbesartan concentration and acute blood pressure reductions in response to irbesartan treatment in Chinese hypertensive patients.
Journal:
Methods Find Exp Clin Pharmacol.
Authors:
Chen G, Jiang S, Mao G, Zhang S, Hong X, Tang G, Li Z, Liu X, Zhang Y, Xing H, Wang B, Yu Y, Xu X.
Publication Date:
2006
PubMed Id: 16541193
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Delineation of human cytochromes P450 involved in the metabolism of tamoxifen.
Journal:
Br J Clin Pharmacol 33:153P, 1992.
Authors:
Daniels, L., Blankson, E.A., Henderson, C.J., Harris, A.H., Wolf, C.R., Lennard, M.S., and Tucker, G.T.
Comprehensive assessment of cytochromes P450 and transporter genetics with endoxifen concentration during tamoxifen treatment
Journal:
Pharmacogenet Genomics. 2017 Nov;27(11):402-409.
Authors:
Marcath LA, Deal AM, Van Wieren E, Danko W, Walko CM, Ibrahim JG, Weck KE, Jones DR, Desta Z, McLeod HL, Carey LA, Irvin WJ Jr, Hertz DL.
Publication Date:
2017
PubMed Id: 28877533
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
|
2C19
|
This is the heading for #1
A Study on CYP2C19 and CYP2D6 Polymorphic Effects on Pharmacokinetics and Pharmacodynamics of Amitriptyline in Healthy Koreans.
Authors:
Ryu, S., Park, S., Lee, J., Kim, Y., Na, H., Lim, H., Choi, H., Hwang, I., Lee, J., Park, Z., Oh, W., Kim, J. and Choi, S
Publication Date:
2017
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Effects of CYP2C19 genetic polymorphism on the steady-state concentration of citalopram in patients with major depressive disorder
Journal:
Pharmacogenomics J. 2021 Aug;21(4):435-439
Authors:
Zastrozhin MS, Skryabin VY, Petukhov AE, Torrado MV, Pankratenko EP, Zastrozhina AK, Grishina EA, Ryzhikova KA, Shipitsyn VV, Bryun EA, Sychev DA
Publication Date:
2021
PubMed Id: 33608663
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Genetic determinants of response to clopidogrel and cardiovascular events.
Journal:
N Engl J Med. 2009
Authors:
Simon T, Verstuyft C, Mary-Krause M, Quteineh L, Drouet E, Méneveau N, Steg PG, Ferrières J, Danchin N, Becquemont L; French Registry of Acute ST-Elevation and Non-ST-Elevation Myocardial Infarction (FAST-MI) Investigators.
Publication Date:
2009
PubMed Id: 19106083
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Comparison of duloxetine, escitalopram, and sertraline effects on cytochrome P450 2D6 function in healthy volunteers.
Journal:
J Clin Psychopharmacol.
Authors:
Preskorn SH, Greenblatt DJ, Flockhart D, Luo Y, Perloff ES, Harmatz JS, Baker B, Klick-Davis A, Desta Z, Burt T.
Publication Date:
2007
PubMed Id: 17224709
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Metabolic disposition of pantoprazole, a proton pump inhibitor, in relation to S-mephenytoin 4'-hydroxylation phenotype and genotype.
Journal:
Clin Pharmacol Ther
Authors:
Tanaka M, Ohkubo T, Otani K, Suzuki A, Kaneko S, Sugawara K, Ryokawa Y, Hakusui H, Yamamori S, Ishizaki T.
Publication Date:
1997
PubMed Id: 9433390
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
|
2D6
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
A Study on CYP2C19 and CYP2D6 Polymorphic Effects on Pharmacokinetics and Pharmacodynamics of Amitriptyline in Healthy Koreans
Journal:
Clinical And Translational Science, 10: 93-101
Authors:
S Ryu, S Park, JH Lee, YR Kim, HS Na, HS Lim, HY Choi, IY Hwang, JG Lee, ZW Park, WY Oh, JM Kim, SE Choi
Publication Date:
2017
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Duloxetine is both an inhibitor and a substrate of cytochrome P4502D6 in healthy volunteers.
Journal:
Clin Pharmacol Ther.
Authors:
Skinner MH, Kuan HY, Pan A, Sathirakul K, Knadler MP, Gonzales CR, Yeo KP, Reddy S, Lim M, Ayan-Oshodi M, Wise SD.
Publication Date:
2003
PubMed Id: 12621382
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6 genotype and use of ondansetron and tropisetron.
Journal:
Clin Pharmacol Ther. 2017 Aug;102(2):213-218.
Authors:
Bell GC, Caudle KE, Whirl-Carrillo M, Gordon RJ, Hikino K, Prows CA, Gaedigk A, Agundez J, Sadhasivam S, Klein TE, Schwab M.
Publication Date:
2017
PubMed Id: 28002639
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
|
2E1
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Benzene poisoning, a risk factor for hematological malignancy, is associated with the NQO1 609C-->T mutation and rapid fractional excretion of chlorzoxazone.
Journal:
Cancer Res
Authors:
Rothman N, Smith MT, Hayes RB, Traver RD, Hoener B, Campleman S, Li GL, Dosemeci M, Linet M, Zhang L, Xi L, Wacholder S, Lu W, Meyer KB, Titenko-Holland N, Stewart JT, Yin S, Ross D.
Publication Date:
1997
PubMed Id: 9230185
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
|
3A4/5
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Acalabrutinib CYP3A-mediated drug–drug interactions: Clinical evaluations and physiologically based pharmacokinetic modelling to inform dose adjustment strategy
Journal:
Br J Clin Pharmacol. 2022; 88(8): 3716-3729
Authors:
Buyun Chen, Diansong Zhou, Hua Wei, Marmor Yotvat, Li Zhou, Jean Cheung, Nicole Sarvaria, Richard Lai, Shringi Sharma, Karthick Vishwanathan, Joseph Ware
Publication Date:
2022
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
In vitro assessment of metabolic drug-drug interaction potential of apixaban through cytochrome P450 phenotyping, inhibition, and induction studies
Journal:
Drug Metab Dispos . 2010 Mar;38(3):448-58.
Authors:
Wang L, Zhang D, Raghavan N, Yao M, Ma L, Frost CE, Maxwell BD, Chen SY, He K, Goosen TC, Humphreys WG, Grossman SJ.
PubMed Id: 19940026
Inhibitors
|
Inducers
|
|
This is the heading for #1
Effects of aprepitant on cytochrome P450 3A4 activity using midazolam as a probe. [ PMID 12891225 ]
Journal:
Clin Pharmacol Ther. 2003 Aug;74(2):150-6.
Authors:
Majumdar AK, McCrea JB, Panebianco DL, Hesney M, Dru J, Constanzer M, Goldberg MR, Murphy G, Gottesdiener KM, Lines CR, Petty KJ, Blum RA.
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
A Phase I study to assess the safety, tolerability and pharmacokinetic profile of boceprevir and sildenafil when dosed separately and together, in healthy male volunteers.
Journal:
J Antimicrob Chemother. 2015;70(6):1812-5.
Authors:
Mora-Peris B, Else L, Goldmeier D, Mears A, Weston R, Cooke G, Khoo S, Back D, Winston A
Publication Date:
2015
PubMed Id: 25693997
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Metabolism of irinotecan (CPt-11) by CYP3A4 and CYP3a5 in humans. [ PMID 10815927 ]
Journal:
Clin Cancer Res. 2000 May;6(5):2012-20.
Authors:
Santos A, Zanetta S, Cresteil T, Deroussent A, Pein F, Raymond E, Vernillet L, Risse ML, Boige V, Gouyette A, Vassal G.
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Metabolism of the immunosuppressant tacrolimus in the small intestine: cytochrome P450, drug interactions, and interindividual variability.
Journal:
Drug Metab Dispos
Authors:
Lampen A, Christians U, Guengerich FP, Watkins PB, Kolars JC, Bader A, Gonschior AK, Dralle H, Hackbarth I, Sewing KF.
Publication Date:
1993
PubMed Id: 8689938
Metabolism of FK506, a potent immunosuppressive agent, by cytochrome P450 3A enzymes in rat, dog and human liver microsomes
Journal:
Biochem Pharmacol
Authors:
Shiraga T, Matsuda H, Nagase K, Iwasaki K, Noda K, Yamazaki H, Shimada T, Funae Y.
Publication Date:
1994
PubMed Id: 7510480
Inhibitors
|
Inducers
|
|
This is the heading for #1
FDA
Publication Date:
2011
Inhibitors
|
Inducers
|
|
This is the heading for #1
Delineation of human cytochromes P450 involved in the metabolism of tamoxifen.
Journal:
Br J Clin Pharmacol
Authors:
Daniels, L, Blankson, EA, Henderson, CJ, Harris, AH, Wolf, CR, Lennard, MS, and Tucker, GT.
Publication Date:
1992
Effects of CYP induction by rifampicin on tamoxifen exposure
Journal:
Clin Pharmacol Ther. 2012 Jul;92(1):62-7
Authors:
Binkhorst L, van Gelder T, Loos WJ, de Jongh FE, Hamberg P, Moghaddam-Helmantel IM, de Jonge E, Jager A, Seynaeve C, van Schaik RH, Verweij J, Mathijssen RH
Publication Date:
2012
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
FDA
Publication Date:
2023
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
This is the heading for #1
Inhibitors
|
Inducers
|
|
|